Nova Eye Medical Limited
ELXMFOTCHealthcare● Active
$0.00
$-0.01(-86.72%)
Market Cap$541249
P/E Ratio—
52W High$0.1
52W Low$0.0019
Nova Eye Medical Limited (ELXMF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ELXMF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $29.27M | $23.32M | $17.02M | $13.38M | $13.39M |
| Cost of Revenue | $10.38M | $3.13M | $16.18M | $14.14M | $11.63M |
| Gross Profit | $18.89M | $20.19M | $0.84M | ($0.77M) | $1.77M |
| Gross Margin %(computed) | 64.54% | 86.57% | 4.95% | -5.72% | 13.20% |
| Operating Expenses | |||||
| R&D Expenses | $3.77M | $4.54M | $0.62M | $0.28M | $0.16M |
| G&A Expenses | $1.85M | $11.78M | $11.26M | $10.04M | $7.87M |
| Total Operating Expenses | $23.39M | $29.16M | $12.69M | $9.12M | $6.73M |
| Operating Income | ($4.50M) | ($8.97M) | ($11.85M) | ($6.59M) | ($4.96M) |
| Operating Margin %(computed) | -15.39% | -38.45% | -69.60% | -49.23% | -37.07% |
| Interest Income | $0.00M | $0.12M | $0.10M | $0.03M | $0.24M |
| Interest Expense | $0.07M | $0.07M | $0.05M | $0.06M | $0.07M |
| Income Before Tax | ($9.06M) | ($8.79M) | ($17.00M) | ($7.82M) | ($5.25M) |
| Income Tax Expense | $0.00M | $0.00M | ($1.71M) | ($0.75M) | ($0.89M) |
| Net Income | ($9.06M) | ($8.79M) | ($15.29M) | ($7.50M) | ($4.36M) |
| Net Margin %(computed) | -30.95% | -37.68% | -89.83% | -56.03% | -32.52% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.04 | $-0.04 | $-0.10 | $-0.05 | $-0.03 |
| Wtd Avg Shares | 247.34M | 204.14M | 160.17M | 148.53M | 147.52M |
| EBITDA | ($6.72M) | ($5.98M) | ($9.48M) | ($7.89M) | ($3.45M) |
| EBITDA Margin %(computed) | -22.97% | -25.63% | -55.69% | -58.96% | -25.76% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · AUD · M
Explore more Nova Eye Medical Limited data
About Nova Eye Medical Limited (ELXMF) Income Statement
Nova Eye Medical Limited (ELXMF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ELXMF reported revenue of $0.03B, gross profit of $0.02B (gross margin 64.54%), and net income of ($0.01B) — a net profit margin of -30.95%.
Frequently asked questions
ELXMF · 4 questionsNova Eye Medical Limited (ELXMF) reported revenue of $0.03B for 2025, up 25.5% year-over-year.
ELXMF revenueELXMF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09